Dimethylphenylpiperazinium

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Dimethylphenylpiperazinium
Dimethylphenylpiperazinium.svg
Systematic (IUPAC) name
1,1-Dimethyl-4-phenylpiperazin-1-ium
Clinical data
Legal status
?
Identifiers
CAS number 114-28-3 N
ATC code ?
PubChem CID 1316
ChemSpider 1276 YesY
ChEMBL CHEMBL134752 YesY
Chemical data
Formula C12H19N2 
Mol. mass 191.29 g/mol
 N (what is this?)  (verify)

Dimethylphenylpiperazinium (DMPP) is a nicotinic acetylcholine receptor agonist which is selective for the ganglionic subtype.[1] One of the earliest reports on the pharmacology of DMPP, describing it as a ganglion-stimulating, hypertensive agent, came from Graham Chen and his co-workers at Parke, Davis & Co.[2]

See also[edit]

References[edit]

  1. ^ Prado WA, Segalla DK (August 2004). "Antinociceptive effects of bethanechol or dimethylphenylpiperazinium in models of phasic or incisional pain in rats". Brain Res. 1018 (2): 272–82. doi:10.1016/j.brainres.2004.05.085. PMID 15276888. 
  2. ^ G. Chen, R. Portman and A. Wickel (1951) J. Pharmacol. Exp. Ther. 103 (1951).